ABSTRACT
Objective:To observe the clinical efficacy of Bairui particles in the treatment of children with acute upper respiratory tract infection. Methods:Totally 180 children with acute upper respiratory tract infection were randomly divided into the control group and the study group. The control group was treated with conventional therapy,such as ribavirin(10 mg·kg-1 ·d-1 ,qd)and so on, and the study group received Bairui particles additionally. The improvement time of clinical symptoms,hospitalization time,clinical ef-ficiency and adverse reactions were compared. Results:Except the rale disappearance time,the improvement time of clinical symptoms and hospitalization time in the study group were shorter than those in the control group(P0. 05). Conclusion:Bairui particles are effective for the children with acute upper respiratory tract infection,which are worthy of wide clinical use.